Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06342635Recruiting

Hydra Single-centre Experience - Copenhagen, Denmark

Role: collaborator

NCT05362370Recruiting

Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performance and Effectiveness

Role: collaborator

NCT05546385Not ApplicableTerminated

PArtial REbreathing for Migraine With Aura 1

Role: collaborator

NCT05874206Not ApplicableRecruiting

CRATOS - Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta Lesions

Role: collaborator

NCT02341534Not ApplicableCompleted

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction

Role: collaborator

NCT04770675Completed

Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.

Role: lead

All 6 trials loaded